Comment on 'Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases': could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?

Moya-Martinez, C; Berná-Rico, E D; Melian-Olivera, A; Moreno-Garcia Del Real, C; Fernández-Nieto, D

Moya-Martinez, C; Berná-Rico, E D; Melian-Olivera, A; Moreno-Garcia Del Real, C; Fernández-Nieto, D.

Afiliação

Moya-Martinez C; Dermatology Department, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain.
Berná-Rico ED; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Melian-Olivera A; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Moreno-Garcia Del Real C; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Fernández-Nieto D; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

J Eur Acad Dermatol Venereol ; 36(2): e95-e97, 2022 02.

Article em En | MEDLINE | ID: mdl-34657329

Assuntos

COVID-19; Exantema; Testes Diagnósticos de Rotina; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exantema / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google